2. Gene
  3. Asns - asparagine synthetase Gene

Asns - asparagine synthetase Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Mus musculus

基因 ID: 27053 | 基因类型: protein coding

关于 Asns

功能概要

Predicted to enable asparagine synthase (glutamine-hydrolyzing) activity and identical protein binding activity. Predicted to be involved in several processes, including asparagine biosynthetic process; cellular response to glucose starvation; and positive regulation of mitotic cell cycle. Predicted to act upstream of or within cellular amino acid biosynthetic process and glutamine metabolic process. Predicted to be active in cytosol. Is expressed in several structures, including alimentary system; eye; genitourinary system; nervous system; and respiratory system. Orthologous to human ASNS (asparagine synthetase (glutamine-hydrolyzing)). [provided by Alliance of Genome Resources, Apr 2022]

Asns 基因产物(6)

mRNA Protein Name
NM_001410605.1 NP_001397534.1 asparagine synthetase [glutamine-hydrolyzing] isoform a
NM_001410606.1 NP_001397535.1 asparagine synthetase [glutamine-hydrolyzing] isoform a
NM_001410607.1 NP_001397536.1 asparagine synthetase [glutamine-hydrolyzing] isoform a
NM_001410608.1 NP_001397537.1 asparagine synthetase [glutamine-hydrolyzing] isoform a
NM_001410609.1 NP_001397538.1 asparagine synthetase [glutamine-hydrolyzing] isoform b
NM_012055.5 NP_036185.1 asparagine synthetase [glutamine-hydrolyzing] isoform a
蛋白主名 其他名称

asparagine synthetase [glutamine-hydrolyzing]

glutamine-dependent asparagine synthetase

相关产品

Approval
生物活性分子 (6)
目录号 产品名 作用方式
纯度 是否罕见病
HY-132254 Sacituzumab govitecan Inhibitor 99.13% 否
HY-N0667 L-Asparagine 98.0% 否
HY-14874 Topiroxostat Inhibitor 99.06% 否
HY-W017443 L-Asparagine monohydrate 99.77% 否
HY-123319 Antofloxacin hydrochloride Inhibitor / 否
HY-123319A Antofloxacin Inhibitor / 否
Clinical Phase
生物活性分子 (7)
目录号 产品名 作用方式
纯度 Phase
HY-P0069 D-JNKI-1 Inhibitor 99.29% Phase 3
HY-132254A Sacituzumab govitecan (solution) Inhibitor 99.10% Phase 2
HY-103018 Gusacitinib Inhibitor 99.41% Phase 2
HY-103018A Gusacitinib hydrochloride Inhibitor / Phase 2
HY-136579 ASN007 Inhibitor 99.70% Phase 1
HY-160196 HC-7366 Inhibitor 99.58% Phase 1
HY-136579A ASN007 benzenesulfonate Inhibitor 99.72% Phase 1
Pre-clinical Phase
生物活性分子 (122)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-128946 CL2A-SN-38 99.97% 否
HY-128923 SKF-34288 hydrochloride Inhibitor 98.61% 否
HY-136626 Z-Ala-Ala-Asn-AMC 99.28% 否
HY-W002327 Fmoc-Asn(Trt)-OH 99.96% 否
HY-112205A RR-11a analog Inhibitor 99.12% 否
HY-108625 SHA 68 Antagonist 99.84% 否
HY-139147 iHCK-37 Inhibitor 99.52% 否
HY-164668 ADC Control Human IgG1-SN-38 97.53% 否
HY-N0667S2 L-Asparagine-15N2 monohydrate 99.0% 否
HY-P4385 (Asn10,Leu11,D-Trp12)-pTH-Related Protein (7-34) amide (human, mouse, rat) Antagonist 99.32% 否
HY-114174 Fmoc-Ala-Glu-Asn-Lys-NH2 99.55% 否
HY-175282 ASX-173 98.32% 否
HY-156586 Egalognastat Inhibitor 99.03% 否
HY-P1341 OXA(17-33) 97.48% 否
HY-N9446 H-Asn(glcnac-beta-D)-OH 98.65% 否
HY-W010378 D-Asparagine 98.0% 否
HY-P1043A NGR peptide Trifluoroacetate 98.91% 否
HY-W009085 Fmoc-Asn-OH 99.19% 否
HY-111323 ASN06917370 99.23% 否
HY-N0667S5 L-Asparagine-d3 hydrate 99.64% 否
HY-128111 ASN02563583 Activator 99.21% 否
HY-W017443S L-Asparagine-13C4,15N2 monohydrate 98.0% 否
HY-B1803A Tracazolate hydrochloride Modulator 99.24% 否
HY-E70068 Endo-β-N-acetylglucosaminidase (Endo S) / 否
HY-113667 ASN04885796 Activator 99.61% 否
HY-148393 G0 N-glycan-Asn 99.95% 否
HY-N0667S3 L-Asparagine-13C4 monohydrate 98.9% 否
HY-150579 Keap1-Nrf2-IN-13 Inhibitor 96.77% 否
HY-P11200 γ-Glu-Asn 98.12% 否
HY-W013330 3′-Deoxyguanosine 97.0% 否
HY-125028 Hck-IN-1 Inhibitor 98.10% 否
HY-150242A Cbz-Ala-Ala-Asn TFA 99.54% 否
HY-162238 OSM-S-106 Inhibitor 99.34% 否
HY-128128 ASN04421891 Modulator 99.00% 否
HY-131092A H-Asn-Arg-OH diTFA 99.83% 否
HY-141464 Fmoc-L-Asn(beta-D-GlcNAc(Ac)3)-OH 95.03% 否
HY-P10485 Glp-Asn-Pro-AMC 99.26% 否
HY-P1809A Velmupressin acetate Agonist 99.47% 否
HY-146535S Daptomycin-D-Asn-d5 TFA / 否
HY-P4279 Ovalbumin (154-159) Inhibitor 99.94% 否
HY-W010378R D-Asparagine (Standard) 99.90% 否
HY-150787 BMS-986339 / 否
HY-129360A Ala-Ala-Asn-PAB TFA / 否
HY-156314 ASN 07115873 Inhibitor 98.76% 否
HY-172473 DSPE-PEG2000-NGR 95.0% 否
HY-175282A (2S,3R,4S)-ASX-173 Control 99.29% 否
HY-176977 Exatecan-mpGly-Asn-Asn-(βAla) 96.25% 否
HY-N0667S L-Asparagine-13C4,15N2,d8 99% 否
HY-P1962 β-Secretase inhibitor Inhibitor 98.06% 否
HY-P2929C PNGase F (Lyophilized) / 否
HY-P3882 Fmoc-Ala-Glu-Gln-Lys-NH2 99.90% 否
HY-W008233 Z-Asn-OH 98.76% 否
HY-W017443S1 L-Asparagine-amide-15N monohydrate 99.80% 否
HY-W017443S2 L-Asparagine-13C4,15N2,d3 monohydrate 99.90% 否
HY-P1809 Velmupressin Agonist / 否
HY-P1810 c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm Agonist / 否
HY-103018S Gusacitinib-d4 / 否
HY-113761 ASN03576800 Inhibitor 99.61% 否
HY-122179 NUCC-555 Antagonist / 否
HY-128947 CL2 Linker / 否
HY-129360 Ala-Ala-Asn-PAB / 否
HY-129361 Fmoc-Ala-Ala-Asn-PABC-PNP / 否
HY-130933 Fmoc-Ala-Ala-Asn(Trt)-OH 99.80% 否
HY-131463 ASN-1377642 Antagonist / 否
HY-136733 Ac-DNLD-CHO Inhibitor / 否
HY-139245 MC-Ala-Ala-Asn-PAB / 否
HY-141149 Fmoc-PEG4-Ala-Ala-Asn-PAB / 否
HY-141150 Azido-PEG5-Ala-Ala-Asn-PAB / 否
HY-141151 Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB / 否
HY-144628 Fmoc-Asn-Pro-Val-PABC-PNP 99.34% 否
HY-144629 Asn-Pro-Val-PABC-MMAE TFA / 否
HY-144630 diSPhMC-Asn-Pro-Val-PABC-MMAE / 否
HY-148031 MC-Ala-Ala-Asn-PAB-PNP / 否
HY-148392 Neu5Gcα(2-6) N-Glycan-Asn / 否
HY-149360 P-gb-IN-1 Inhibitor / 否
HY-151146 (1R,3S)-THCCA-Asn Inhibitor / 否
HY-164457 ASN-001 Inhibitor / 否
HY-172472 DSPE-PEG1000-NGR / 否
HY-172473A DSPE-PEG3400-NGR / 否
HY-172474 DSPE-PEG5000-NGR / 否
HY-174223 α-Glucosidase-IN-90 Inhibitor / 否
HY-180467 Neu5Ac-2Galβ1-3Glc-oxazoline-(2)Me / 否
HY-185461 Mc-Asn-Asn-E104 Agonist / 否
HY-185462 Mc-Asn-Asn / 否
HY-78162 cis-3-Hydroxyproline Substrate / 否
HY-E71264 β-Acetylglucosaminidase 18A, Bacteroides thetaiotaomicron / 否
HY-N0667S1 L-Asparagine-15N2,d8 / 否
HY-N0667S4 L-Asparagine-4-13C monohydrate / 否
HY-N0667S7 L-Asparagine-13C4,15N2 / 否
HY-N15365 Antcin B Inhibitor / 否
HY-P11408 [D-Cys6,Asn7,D-Ala11,Cys14]-Bombesin (6-14) Agonist / 否
HY-P11620 H-Asn-Pro-Glu-Tyr(PO3H2)-OH / 否
HY-P1610 Asudemotide Inducer / 否
HY-P2212 (Asn1,Val5)-Angiotensin II / 否
HY-P2397 Fmoc-Asn(Trt)-Thr(psi(Me,Me)pro)-OH / 否
HY-P2401 Fmoc-Asn(Trt)-Ser(psi(Me,Me)pro)-OH / 否
HY-P3220 [D-Asn5]-Oxytocin Activator / 否
HY-P3615 [Asn18] Endothelin-1 (swine, human) Agonist / 否
HY-P3716 H(-Asn-Pro-Asn-Ala)2-OH / 否
HY-P4019 Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 / 否
HY-P4407 (D-Asn28)-Exenatide Control / 否
HY-P4893 (Gln22,Asn23)-Amyloid β-Protein (1-40) / 否
HY-P4919 Mca-SEVNLDAEFK(Dnp) / 否
HY-P5331 [Asn23]-beta-Amyloid (1-42), iowa mutation / 否
HY-P5365 [Asn23] β-Amyloid (1-40), Iowa mutation / 否
HY-P5415 DABCYL-GABA-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS / 否
HY-RS01098 ASNS Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-W017443S3 L-Asparagine-15N2,d3 monohydrate / 否
HY-W017443S4 L-Asparagine-1,2,3,4-13C4 monohydrate / 否
HY-W091365 Boc-Asn(Xan)-OH / 否
HY-118731 TNK-6123 Activator / 否
HY-131092 H-Asn-Arg-OH / 否
HY-141152 Azido-PEG4-Ala-Ala-Asn(Trt)-PAB / 否
HY-141153 Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB-PNP / 否
HY-148389 Disialo-Asn / 否
HY-151829 Fmoc-L-Asn(EDA-N3)-OH / 否
HY-157338 NHS-Ala-Ala-Asn-active metabolite Inhibitor / 否
HY-RS19117 Asns Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS25607 Asns Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-W002327S Fmoc-Asn(Trt)-OH-13C4,15N2 96.9% 否
HY-W173361 CBP/p300-IN-24 Inhibitor / 否
HY-P1043 NGR peptide 99.73% 否
抗体抑制剂 (1)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P991497 ASN-500 Inhibitor / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens Asns NCBI NCBI:440
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z